EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Wearable Telemonitoring in Focal Spasticity: A Prospective Exploratory Pilot Study of Daily-Life Mobility Monitoring

Theodoros Saganas, Spyridon Votis, Fotios Kantas, Foivos S. Kanellos, Georgios Rigas, Andreas P. Katsenos, Yannis V. Simos, Lampros Lakkas, Georgios S. Markopoulos, Vasiliki Kostadima, Spyridon Konitsiotis, Dimitrios Peschos und 1 weitere

Signals · 16.07.2026 · 7 (4) · 70

DOI: 10.3390/signals7040070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Signals, online erschienen am 16.07.2026. Verfasst von Theodoros Saganas und 12 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spasticity is a common and disabling consequence of upper motor neuron lesions, and its follow-up relies largely on clinical scales that may not fully reflect daily-life mobility. This prospective single-arm exploratory pilot study examined wearable-derived daily-life mobility metrics around a scheduled botulinum neurotoxin type A (BoNT-A) injection cycle and assessed their associations with established clinical measures. Thirteen patients with focal spasticity secondary to stroke (n = 11) or multiple sclerosis (n = 2) underwent baseline and 6-week follow-up assessment using the Modified Ashworth Scale (MAS), Motricity Index (MI), the Timed Up and Go test (TUG) and a multi-sensor wearable monitoring system. Device-derived outcomes included gait impairment, gait speed, stride length, angular velocity, and lack of movement. Clinical scales generally changed in the expected post-treatment direction, with reduced MAS scores and descriptive or directional improvements in MI scores and TUG performance. Wearable metrics captured descriptive changes in daily mobility, notably a reduction in lack of movement. Furthermore, in exploratory pooled analyses, selected gait-related metrics tended to be associated with TUG performance and lower-extremity MAS. These findings highlight the potential of wearable telemonitoring to complement conventional clinical scales by providing objective, real-world data, supporting its further validation as a tool for longitudinal spasticity management and neurorehabilitation. These device-derived metrics should be interpreted as mobility-related digital biomarkers rather than direct surrogate measures of spasticity.

Zitieren

APA

Saganas, T., Votis, S., Kantas, F., Kanellos, F. S., Rigas, G., Katsenos, A. P., Simos, Y. V., Lakkas, L., Markopoulos, G. S., Kostadima, V., Konitsiotis, S., Peschos, D., & Tsamis, K. I. (2026). Wearable Telemonitoring in Focal Spasticity: A Prospective Exploratory Pilot Study of Daily-Life Mobility Monitoring. Signals, 7(4), 70. https://doi.org/10.3390/signals7040070

Vancouver

Saganas T, Votis S, Kantas F, Kanellos FS, Rigas G, Katsenos AP, et al. Wearable Telemonitoring in Focal Spasticity: A Prospective Exploratory Pilot Study of Daily-Life Mobility Monitoring. Signals. 2026;7(4):70. doi:10.3390/signals7040070

BibTeX
@article{Saganas2026,
  author = {Saganas, Theodoros and Votis, Spyridon and Kantas, Fotios and Kanellos, Foivos S. and Rigas, Georgios and Katsenos, Andreas P. and Simos, Yannis V. and Lakkas, Lampros and Markopoulos, Georgios S. and Kostadima, Vasiliki and Konitsiotis, Spyridon and Peschos, Dimitrios and Tsamis, Konstantinos I.},
  title = {Wearable Telemonitoring in Focal Spasticity: A Prospective Exploratory Pilot Study of Daily-Life Mobility Monitoring},
  journal = {Signals},
  year = {2026},
  volume = {7},
  number = {4},
  pages = {70},
  doi = {10.3390/signals7040070}
}
Kostenlos starten →